Biosimilar medicationsnewer biologics that are highly similar to established biologic medications whose patent protections have expiredare becoming part of the treatment landscape in the United States. Biosimilars are still novel enough that many patients, and even clinicians, may be confused about their role in treatment plans and how they differ from and are similar to the biologic drugs on which they are based. This interactive activity is intended to provide insight on how to help patients understand key concepts related to biosimilar medications.
Ratings and Reviews
To review this course, please login.Login